The importance of patient fitness in expert and multidisciplinary multiparametric management of HCC: a narrative review

Importance of critical tumor features in multidisciplinary multi-parametric assessment of HCC

Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept

The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma

Impact of SARS-CoV-2 Pandemic on the Management of Patients with Hepatocellular Carcinoma

Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC Classifications

Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice

Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics

Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis

Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows